Table of Contents List of Tables List of Figures Introduction Global Markets Direct Report Coverage Venous Leg Ulcers (Crural ulcer) - Overview Venous Leg Ulcers (Crural ulcer) - Therapeutics Development Pipeline Overview Pipeline by Companies Products under Development by Companies Venous Leg Ulcers (Crural ulcer) - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Venous Leg Ulcers (Crural ulcer) - Companies Involved in Therapeutics Development CardioVascular BioTherapeutics Inc CytoTools AG Daval International Ltd Factor Therapeutics Ltd FirstString Research Inc GangaGen Inc MediWound Ltd NovaLead Pharma Pvt Ltd Promore Pharma Stratatech Corp Venous Leg Ulcers (Crural ulcer) - Drug Profiles Aimspro - Drug Profile Product Description Mechanism Of Action R&D Progress AUP-16 - Drug Profile Product Description Mechanism Of Action R&D Progress Cell Therapy to Activate Cathelicidin for Diabetic Foot Ulcers and Crural Ulcer - Drug Profile Product Description Mechanism Of Action R&D Progress Cell Therapy to Activate VEGF for Venous Leg Ulcers and Diabetic Foot Ulcers - Drug Profile Product Description Mechanism Of Action R&D Progress CVBT-141B - Drug Profile Product Description Mechanism Of Action R&D Progress diperoxochloric acid - Drug Profile Product Description Mechanism Of Action R&D Progress EscharEx - Drug Profile Product Description Mechanism Of Action R&D Progress Granexin - Drug Profile Product Description Mechanism Of Action R&D Progress LL-37 - Drug Profile Product Description Mechanism Of Action R&D Progress NLP-328 - Drug Profile Product Description Mechanism Of Action R&D Progress P-128 - Drug Profile Product Description Mechanism Of Action R&D Progress S-42909 - Drug Profile Product Description Mechanism Of Action R&D Progress sodium hypochlorite - Drug Profile Product Description Mechanism Of Action R&D Progress VF-001 - Drug Profile Product Description Mechanism Of Action R&D Progress Venous Leg Ulcers (Crural ulcer) - Dormant Projects Venous Leg Ulcers (Crural ulcer) - Discontinued Products Venous Leg Ulcers (Crural ulcer) - Product Development Milestones Featured News & Press Releases Nov 29, 2017: Factor Therapeutics Announces 50% Recruitment Reached in VF00102 Clinical Trial Nov 02, 2017: VF001002 Clinical Trial Update: Strong performance in October driven by new sites Oct 31, 2017: Promore Pharma Signs Agreement with CRO PCG Clinical Services Sep 21, 2017: Promore Pharma Signs Manufacturing Agreement with APL Sep 12, 2017: Promore Pharma presents at the symposium for hard-to-heal wounds in connection with Nordic Life Science Days Sep 01, 2017: MediWound Successfully Completes Second Cohort of EscharEx Phase 2 Study May 22, 2017: Factor Therapeutics Appoints Dr. Rosalind Wilson as CEO Apr 07, 2017: Factor Therapeutics: Phase II Clinical Trial Progress Update Dec 20, 2016: Factor Therapeutics - First Patient In and Clinical Update Nov 07

List of Tables Number of Products under Development for Venous Leg Ulcers (Crural ulcer), H1 2018 Number of Products under Development by Companies, H1 2018 Products under Development by Companies, H1 2018 Number of Products by Stage and Target, H1 2018 Number of Products by Stage and Mechanism of Action, H1 2018 Number of Products by Stage and Route of Administration, H1 2018 Number of Products by Stage and Molecule Type, H1 2018 Venous Leg Ulcers (Crural ulcer) - Pipeline by CardioVascular BioTherapeutics Inc, H1 2018 Venous Leg Ulcers (Crural ulcer) - Pipeline by CytoTools AG, H1 2018 Venous Leg Ulcers (Crural ulcer) - Pipeline by Daval International Ltd, H1 2018 Venous Leg Ulcers (Crural ulcer) - Pipeline by Factor Therapeutics Ltd, H1 2018 Venous Leg Ulcers (Crural ulcer) - Pipeline by FirstString Research Inc, H1 2018 Venous Leg Ulcers (Crural ulcer) - Pipeline by GangaGen Inc, H1 2018 Venous Leg Ulcers (Crural ulcer) - Pipeline by MediWound Ltd, H1 2018 Venous Leg Ulcers (Crural ulcer) - Pipeline by NovaLead Pharma Pvt Ltd, H1 2018 Venous Leg Ulcers (Crural ulcer) - Pipeline by Promore Pharma, H1 2018 Venous Leg Ulcers (Crural ulcer) - Pipeline by Stratatech Corp, H1 2018 Venous Leg Ulcers (Crural ulcer) - Dormant Projects, H1 2018 Venous Leg Ulcers (Crural ulcer) - Discontinued Products, H1 2018 List of Figures Number of Products under Development for Venous Leg Ulcers (Crural ulcer), H1 2018 Number of Products under Development by Companies, H1 2018 Number of Products by Top 10 Targets, H1 2018 Number of Products by Stage and Top 10 Targets, H1 2018 Number of Products by Mechanism of Actions, H1 2018 Number of Products by Stage and Mechanism of Actions, H1 2018 Number of Products by Routes of Administration, H1 2018 Number of Products by Stage and Routes of Administration, H1 2018 Number of Products by Molecule Types, H1 2018 Number of Products by Stage and Molecule Types, H1 2018

CardioVascular BioTherapeutics Inc CytoTools AG Daval International Ltd Factor Therapeutics Ltd FirstString Research Inc GangaGen Inc MediWound Ltd NovaLead Pharma Pvt Ltd Promore Pharma Stratatech Corp